CBOE to List Options on HEMISPHERIx BIOPHARMA, Inc. on Thursday, Oct. 8
Thursday October 1, 3:04 pm Eastern Time
Company Press Release
SOURCE: Chicago Board Options Exchange
CHICAGO, Oct. 1 /PRNewswire/ -- The Chicago Board Options Exchange (CBOE) today announced it will begin trading options on HEMISPHERIx BIOPHARMA, Inc. (Amex: HEB; CBOE) on Thursday, Oct. 8.
HEMISPHERIx BIOPHARMA, Inc., located in Philadelphia, Pa., is a biopharmaceutical company that uses nucleic acid technologies to develop therapeutic products for the treatment of viral diseases and disorders of the immune systems.
HEB options will trade on the February expiration cycle with introductory expirations in October, November, February and May. Initial strike prices have been set at 5, 7 1/2 and 10. Susquehanna Investment Group has been named the Designated Primary Market Maker (DPM) in the options.
CBOE, regulated by the Securities and Exchange Commission (SEC), is the pioneer of listed options and the world's largest options marketplace. For additional information about the CBOE and its products, access the CBOE site on the World Wide Web at cboe.com.
SOURCE: Chicago Board Options Exchange |
